Mediclinic International plc, the international private healthcare services group, has hosted a Capital Markets Day event and site visit for analysts and investors in Zurich, Switzerland at the 28.06.2018. No new material information was provided during the event and guidance remains unchanged with trading in line with expectations.

The event included presentations from the Group’s CEO and CFO in addition to operationalreviews from the divisional CEO’s of Hirslanden, Mediclinic Southern Africa and Mediclinic Middle East.

The key theme for the day is Mediclinic’s tailored approach to value creation focusing on:

  • Our diversified international presence and unified focus
  • Strong healthcare market potential
  • Our unique approach to creating value putting patients at the core of our business
  • Our focus on international growth opportunities
  • Our management skills and expertise
  • Financial discipline across the Group

Webcast replay

There is a replay of the webcast available via the following link:

About Mediclinic International plc

Mediclinic is an international private healthcare services group, established in South Africa in 1983, with current operating divisions in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, an LSE-listed and UK-based private healthcare group.
As at the date of this announcement, Mediclinic comprises 75 hospitals and 28 outpatient clinics. Hirslanden operates 17 private hospitals and 4 clinics in Switzerland with more than 1 800 inpatient beds; Mediclinic Southern Africa operates 49 hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 100 inpatient beds in total; and Mediclinic Middle East operates 6 hospitals and 22 clinics with more than 700 inpatient beds in the United Arab Emirates.
Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia.


Investor Contacts
James Arnold
Head of Investor Relations
Media Contacts
FTI Consulting